Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 257

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 257
---
the same effect in all three scenarios) which includes: (i) Recognition of listing services of $61.92million; and (ii) Assumption of APx incremental transaction expenses not recognized as liabilities in its historical statement of financial position as of December31, 2024 which amounts to $3.76million. For more information, see section “Share premium”. Any change in the estimated fair value of identifiable net assets/(liabilities) of APx upon closing of the Business Combination could have a material impact on the calculation of the estimated listing fee. APx reported an estimated warrant liability related to its public and private warrants of $1.4million as of December31, 2024 that is included in the calculation of the listing charge of $61.9million included in these pro forma financial statements assuming the Business Combination occurred on December31, 2024. APx reported an estimated warrant liability related to its public and private warrants of $4.7million as of March31, 2025, an increase in the liability of $3.3million as compared to December31, 2024. An increase of $3.3million in the estimated warrant liability as of December31, 2024 would have increased the estimated pro forma listing fee expense by an additional $3.3million for a total charge of $65.2million on a pro forma basis. (5)Heritas Argentina, a subsidiary of OmnigenicsAI, received financing from existing credit facilities after December31, 2024, in the total amount of $178,006 ($81,996 from Bioceres S.A. and $96,010 from CIBIC). The terms of these loan agreements include interest rates of 6.5% per annum, with maturity dates in January 2028. For pro forma purposes, said financings are treated as if they were performed on July 1, 2023. In consequence: •in the Unaudited Pro Forma Combined Statement of Operations for the six -monthperiod ended December31, 2024, accrued interests of these borrowings amounted to $5,801; and •in the Unaudited Pro Forma Combined Statement of Operations for the twelve -monthperiod ended June30, 2024, accrued interests of these borrowings amounted to $11,570; and. •in the Unaudited Pro Forma Combined Statement of Financial Position as of December31, 2024, non -currentfinancial debt amounted to $178,006